NKTR
Nektar Therapeutics · Healthcare
Deep Track Capital, LP sold $100K of Nektar Therapeutics
10% owner
Sold$99,630
$1.78Price
56,000Shares
What NKTR did after the filing
- The stock from Tue, May 14 open, $25.80
- −33.7%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Jun 27 close.
Traded Fri, May 10. Filed Mon, May 13, 4:36 PM ET, after the close. Returns use the May 14 open and the Jun 27 close. Not investment advice.